GlassScriptPhysician profile
Sabrina Huq
NPI 1417349473
$4,588.33
in general payments reported to CMS, 2019-2025
16 companies · $1,398 in 2025
The $1,398 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $258 · 2023: $698 · 2024: $2,234 · 2025: $1,398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,330.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $742.76 | 2024-2025 | |
| Dexcom, INC. | $689.66 | 2023-2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor, Dexcom G6 Transmitter |
| Abbott Laboratories | $517.39 | 2021-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Amgen INC. | $508.69 | 2024-2025 | Tepezza |
| Xeris Pharmaceuticals, INC. | $493.99 | 2024-2025 | Gvoke Hypopen |
| Insulet Corporation | $464.00 | 2024-2025 | Omnipod, Omnipod |
| Novo Nordisk INC | $200.71 | 2023-2024 | Wegovy |
| Medline Industries LP | $160.99 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2025 | Wainua |
| Horizon Therapeutics Plc | $125.00 | 2023 | Tepezza |
| Bayer Healthcare Pharmaceuticals INC. | $124.73 | 2024 | |
| Intuity Medical INC | $109.23 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Pfizer INC. | $107.12 | 2024 | |
| Amryt Pharma Holdings LTD | $88.28 | 2023 | Mycapssa |
| Cequr Corporation | $77.00 | 2024 | Cequr Simplicity |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Global Blood Therapeutics, INC. | $53.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sabrina Huq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.